IFN-␥ is critical for innate immunity against
L
isteria monocytogenes is an intracellular bacterial pathogen that has been used for decades as a model organism to study cell-mediated immunity. Systemic infection can be established via i.v. administration of bacteria in most of the commonly studied inbred strains of mice. However, there is a significant difference among mouse strains in the degree of susceptibility to L. monocytogenes, as measured by both bacterial burden following sublethal infection and LD 50 values. For example, in a previous study we showed that 2-5 ϫ 10 4 CFU of L. monocytogenes strain 10403s caused death of all BALB/c mice within 72 h, while C57BL/6 mice, which have an LD 50 that is at least 50-fold higher, all survived infection with this dose of L. monocytogenes (1) . Complement (C5) deficiency and a sst1-dependent macrophage function have been implicated in innate host susceptibility to L. monocytogenes infection (2, 3) . However, host resistance appears to be a multigenic trait (1) , and further genetic differences between mouse strains have yet to be identified.
IFN-␥ is a critical cytokine involved in control of L. monocytogenes infection during both the innate and adaptive immune responses. NK cells and NKT cells are known to secrete IFN-␥ and are thought to limit exponential growth of the bacteria primarily by activating macrophages during the first few days of infection (4, 5) . IFN-␥ secretion by these cells is also thought to promote a Th1 type response against Listeria by increasing MHC class I expression. The adaptive immune response against L. monocytogenes, which peaks at 6 -8 days postinfection, is dominated by CD8 ϩ T cells, which have two main effector functions: specific lysis of infected cells and secretion of IFN-␥. CD8
ϩ T cells are essential for complete clearance of the bacterial burden and provide longlasting sterilizing immunity against L. monocytogenes (6, 7). Intriguing recent studies suggest that CD8 ϩ T cells can also function during the innate phase of immunity (8 -10) . In fact, Berg et al. showed that on a cell-for-cell basis, CD8
ϩ T cells may contribute as much IFN-␥ as NK cells during the first 3 days of L. monocytogenes infection (11) . They further demonstrated that IFN-␥-secreting CD8 ϩ T cells were found in the T cell zones of the white pulp of the spleen close to infected macrophages while NK cells were limited to red pulp regions and did not colocalize with foci of infection (12) . These results suggest that CD8 ϩ T cell derived IFN-␥ may be more effective at bacterial control than NK cell-derived cytokine.
The subpopulation of CD8 ϩ T cells capable of rapidly secreting IFN-␥ in response to L. monocytogenes infection has been partially characterized. Berg et al. (11) showed that the early IFN-␥ response by CD8 ϩ T cells is IL-12 and IL-18 dependent and Ag independent and that the cells appeared to have a memory phenotype (CD44 high Ly6C high CD62L low ). In an adoptive transfer experiment, more than half of the transferred memory T cells secreted IFN-␥ within 16 h of infection with L. monocytogenes, suggesting that the early IFN-␥ response may be an inherent characteristic of memory CD8 ϩ T cells (8) . It has been suggested that memory CD8 ϩ T cells have higher levels of IL-12 and IL-18 receptors on their surface, thus accounting for the ability to rapidly secrete IFN-␥ in response to IL-12 and IL-18 production by L. monocytogenes-infected macrophages and/or dendritic cells (DC) 3 (8) .
In this study, we examined the bacterial components that trigger the early IFN-␥ response. We showed that cytosolic localization of L. monocytogenes was required to induce IFN-␥ secretion by memory CD8
ϩ T cells and that other bacterial pathogens did not trigger this response. We found that only half of the mouse strains we tested (including C57BL/6, 129, and NZB) were capable of mounting an early IFN-␥ response by memory CD8 ϩ T cells. Furthermore, the early IFN-␥ response appeared to correlate with innate host resistance to L. monocytogenes since the CD8 ϩ T cells from the most susceptible mouse strains (BALB/c, A/J, and SJL) were not capable of rapidly secreting IFN-␥. These results suggest that initial clearance of L. monocytogenes infection occurs by different mechanisms in the commonly studied BALB/c and C57BL/6 mouse models.
Materials and Methods

Mice
BALB/c/By/J, C57BL/6/J (B6), C.B10-H2 b /LilMcd/J (C.B10), BALB ϫ B6 F 1 , 129/3/J, NZB, A/J, and SJL mice were obtained from The Jackson Laboratory and were maintained in a specific-pathogen free facility at either Harvard Medical School or the University of Kentucky. C.B10 is a congenic strain identical to BALB/c (H-2 d ) at all loci, except for the H-2 locus, which was derived from a C57BL/10 (H-2 b ) mouse. 
Bacteria and viruses
Infection of mice
For bacterial infections, mice were inoculated i.v. in the lateral tail vein using a total volume of 200 l. The LD 50 for L. monocytogenes 10403s is ϳ1 ϫ 10 4 for BALB/c mice and ϳ2 ϫ 10 5 for C57BL/6 mice. To determine bacterial burden, mice were sacrificed, and their spleens and livers were harvested aseptically and homogenized in 0.2% Nonidet P-40. Serial dilutions were plated on tryptic soy agar containing 10 g/ml streptomycin, and the total number of colony-forming units was determined following overnight incubation at 37°C. Vaccinia virus preparations were treated with an equal volume of 0.25 mg/ml trypsin for 30 min at 37°C and diluted in PBS. Mice were infected either i.p. or i.v. with 1 ϫ 10 6 PFU of virus.
Infection of bone marrow-derived macrophages (BMM) and DC
To generate BMM, bone marrow cells were harvested from the femurs of mice and plated in BMM-20 medium, consisting of DMEM (11960; Invitrogen Life Technologies) supplemented with L-glutamine, 20% FCS, and 20% L929 supernatant. On day 4, cells were washed once with PBS and replenished with BMM-20. BMM were then fed with BMM-10 every 3-4 days and maintained in culture for up to 6 wk as described previously (15) . CD11c ϩ DC were isolated from mouse spleen by negative selection with Ab-coated magnetic beads. Cells were infected at a multiplicity of infection (MOI) of 1 (M) or 5 (DC) for 30 min at 37°C in 7% CO 2 . Contact between the cells and the bacteria was facilitated by centrifugation of the tissue culture dishes at 600 ϫ g for 5 min at 35°C. The cells were washed three times with prewarmed PBS, and then RP-10 containing 25 g/ml gentamicin was added to kill extracellular bacteria.
Abs/flow cytometry
CD8
ϩ or CD11c ϩ cell populations were enriched from mouse spleen by negative selection using IMag mixtures of Ab-coated magnetic beads according to the manufacturer's instructions (BD Biosciences). Fluorescently conjugated anti-murine Abs directed against IFN-␥ (clone XMG1.2), CD8␣ (53-6.7), TCR␤ (H57-597), and CD44 (IM7) and were purchased from eBioscience. Biotin-labeled anti-mouse IL-12R␤1 (clone 114) and PE-Cy5 conjugated streptavidin were purchased from BD Biosciences. Purified mAbs against murine IL-12 (PeproTech) and murine IL-18 (clone 93-10C; Medical & Biological Labs) were used at a final concentration of 1 g/ml. Cells were suspended in FACS buffer consisting of HBSS with 0.5% BSA and 0.1% sodium azide. Fluorescence intensities were measured using a FACSCalibur flow cytometer, and analysis was performed using CellQuest software (BD Biosciences). Dead cells and monocytes were excluded using forward and side scatter gating.
Intracellular cytokine staining (ICCS)
Intracellular staining for IFN-␥ was performed using the Cytofix/Cytoperm (with GolgiPlug) kit, according to the manufacturer's instructions (BD Biosciences). For ex vivo assays, spleens were harvested 18 h postinfection, and 5 ϫ 10 6 splenocytes were plated in RP-10 in 24-well dishes (2 ml/well) in the presence of GolgiPlug (2 l/well) with no further in vitro stimulation. For in vitro assays, 5 ϫ 10 5 BMM were infected for 1 h, and then 5 ϫ 10 6 naive splenocytes were added to each well. The cells were coincubated at 37°C in 7% CO 2 for 18 -20 h, with Golgi Plug added to the medium during the last 4 h of incubation. Typically, 50,000 lymphocytes (based on forward and side scatter gating) were collected and analyzed.
Infection with Escherichia coli expressing LLO and OVA E. coli DH5␣ harboring pDP3616 (E. coli OVA; Amp R ) and E. coli DH5␣ harboring both pDP3615 (Cm R ) and pDP3616 (E. coli LLO/OVA) were provided by D. Higgins. pDP3616 encodes a truncated form of OVA under the control of an IPTG-inducible T7 promoter; pDP3615 contains the hly gene encoding LLO (lacking the secretion signal sequence) under the control of a constitutive tet promoter (16) . The E. coli strains were grown on Luria-Bertani (LB) agar plates containing 10 g/ml chloramphenicol and/or 50 g/ml carbenicillin, and a fresh colony was used to inoculate 2 ml of LB broth containing the appropriate antibiotics. Cultures were grown to stationary phase overnight at 37°C with aeration and then diluted 1/100 into fresh medium. Expression of OVA was induced by adding 1 mM IPTG to mid-log phase cultures (OD 600 ϭ 0.5) and growth was continued for an additional 2 h at 37°C with aeration. Equivalent numbers of bacteria were washed once in PBS and used to infect tissue culture cells or mice. Serial dilutions of the inocula were plated on LB agar containing appropriate antibiotics to determine the total number of colony-forming units present.
Cytotoxicity assays
Effector cell populations were generated by harvesting splenocytes from immune mice (14 days postinfection) and incubating for 5 days in vitro (37°C in 7% CO 2 ) in the presence of irradiated (2000 rad) syngeneic peptide-coated (final concentration of 100 nM) splenocytes. Synthetic peptides corresponding to the LLO 91-99 and OVA 257-264 epitopes were purchased from Bio-Synthesis. Target cells (10 6 ) were prepared by coincubating either EL-4 thymoma (H-2 b ) or P815 mastocytoma (H-2 d ) cells with the appropriate peptide epitope (final concentration of 100 nM) and 100 Ci of sodium [
51 Cr]chromate for 1 h at 37°C in 7% CO 2 in a total volume of 150 l. Target cells were washed three times with RPMI 1640, suspended in RP-10 at 1 ϫ 10 5 cells/ml, and distributed into 96-well plates (100 l/ well). Serial dilutions of the effector cell cultures (100 l/well) were added, and the plates were incubated for 4 h at 37°C in 7% CO 2 . The assay plates were centrifuged for at 500 ϫ g for 5 min, and 100 l of the supernatant from each well was applied to a Luma plate (PerkinElmer) and allowed to dry overnight at room temperature. The amount of 51 Cr released into the supernatant of each well was evaluated (without the addition of scintillation fluid) using a TopCount (PerkinElmer) gamma counter. Spontaneous release (SR) was determined by incubating target cells in RP-10 alone (no effector cells); maximum release (MR) was determined by incubating target cells in RP-10 with 0.1% Triton X-100. Percent-specific lysis (SL) was calculated using the following formula: percentage of SL ϭ 100 ϫ (release by effector T cells Ϫ SR)/(MR Ϫ SR)).
Results
Only L. monocytogenes infection triggers the early IFN-␥ response
Previous work has demonstrated that CD44
ϩ CD8 ϩ T cells in C57BL/6 mice secrete significant amounts of IFN-␥ within 16 h of infection with the intracellular bacterial pathogen L. monocytogenes (8, 11) . Although these memory T cells responded to infection in an Ag-independent manner, they appeared to play a role in the clearance of L. monocytogenes. To determine whether this early IFN-␥ response was involved in the clearance of other intracellular pathogens, we infected C57BL/6 mice i.v. with S. typhimurium, C. trachomatis, and Vaccinia virus. Splenocytes were harvested from these mice 18 h after infection and incubated for 4 h in vitro in the presence of brefeldin A to block protein secretion. The number of CD8 ϩ T cells secreting IFN-␥ ex vivo was assessed by intracellular cytokine staining. Consistent with the earlier findings of Berg et al. (11), ϳ3% of the CD8 ϩ T cells in L. monocytogenes-infected mice secreted IFN-␥ (Fig. 1A) . However, none of the mice infected with Salmonella, Vaccinia, or Chlamydia demonstrated an increase in IFN-␥-secreting CD8 ϩ T cells over the background level detected in naive mice. Since C. trachomatis replicates much more slowly than Salmonella or Vaccinia virus, we also examined splenocytes harvested from C57BL/6 mice 36 h postinfection with C. trachomatis. Although the level of IFN-␥ ϩ CD8 ϩ T cells was slightly higher at 36 h compared with 18 h postinfection, it was not significantly different from the number of IFN-␥ ϩ T cells found in the spleens of naive mice (Fig. 1A) .
One difference between L. monocytogenes and the other intracellular bacterial pathogens we tested is cell wall composition. L. monocytogenes is a Gram-positive organism, whereas Salmonella spp. are Gram-negative and C. trachomatis has a Gram-negativelike cell wall. Thus, it was possible that the presence of a Grampositive cell wall component, such as lipoteichoic acid, was responsible for triggering the early IFN-␥ response. To test this possibility, we infected C57BL/6 mice i.v. with three other Grampositive organisms: a nonpathogenic Listeria (L. innocua), the closely related Bacillus subtilis, or Streptococcus pyogenes. As shown in Fig. 1 , B and C, there was no increase in the number of IFN-␥ ϩ CD8 ϩ T cells in these mice 18 h postinfection. These results indicate that not all Gram-positive bacteria are capable of triggering the early IFN-␥ response. Taken together, these data suggest that L. monocytogenes infection is unique in its ability to cause rapid secretion of IFN-␥ by CD8 ϩ T cells.
Cytosolic localization of L. monocytogenes is required to trigger the early IFN-␥ response
Upon infection of host cells, L. monocytogenes rapidly escapes from phagocytic or endocytic vacuoles into the host cell cytosol. In contrast, C. trachomatis and S. typhimurium are intracellular bacteria that survive and multiply within phagocytic vacuoles. If cytosolic localization were required to trigger the early IFN-␥ effect, then it would not be surprising that Lm was the only one of these three pathogens that triggered rapid IFN-␥ secretion by CD8 ϩ T cells. To test this, we infected C57BL/6 mice with either 10 9 HK Lm or 10 8 CFU of either L. innocua or an LLO deletion mutant strain of L. monocytogenes (⌬LLO L. monocytogenes). Since LLO is not actively secreted by any of these bacterial strains, the organisms should remain within host cell vacuoles during infection of mice. As shown in Fig. 2 , no increase in the number of IFN-
ϩ T cells was observed within 18 h of infection with any of these strains. These results suggested that the Listeria product responsible for triggering the early IFN-␥ effect must be localized to the host cell cytosol.
E. coli expressing cytosolic LLO can trigger the early IFN-␥ response
Recombinant LLO has been shown to induce cytokine production in vitro when incubated with mouse splenocytes (16, 17) . Thus, we considered the possibility that LLO itself could trigger the early IFN-␥ response by memory CD8 ϩ T cells in the absence of other L. monocytogenes components. To test this, we infected mice with E. coli strains expressing either LLO and the heterologous antigenic protein OVA (E. coli-OVA/LLO) or OVA alone (E. coli-OVA). E. coli expressing recombinant LLO do not actively secrete LLO and thus do not have the ability to escape from phagocytic vacuoles. However, degradation of E. coli strains expressing LLO is thought to release preformed stores of active hemolysin that form pores in the phagocytic membrane, releasing abundant bacterial proteins into the host cell cytosol (18) . E. coli strains overexpressing target Ags such as OVA in combination with LLO have been shown to deliver a K b -restricted OVA epitope (SIINFEKL) to the host cell cytosol for processing and presentation to CD8 ϩ T cells and thus have been used as an intracellular vaccine delivery system in both murine and human DC (19, 20) .
As shown in Fig. 3A , infection with 10 7 CFU of either E. coli strain did not trigger the early IFN-␥ response. However, increasing the dose to 10 8 CFU resulted in an increase in IFN-␥ ϩ CD8 ϩ T cells in mice infected with E. coli-OVA/LLO but not in mice infected with Ec-OVA. To verify that significant amounts of bacterial proteins were being released into the host cell cytosol during these infections, we also looked for activation of either SIINFEKL or LLO 91-99 -specific CD8 ϩ T cells following infection with the recombinant E. coli strains. Two weeks postinfection, splenocytes were harvested from these mice and incubated in vitro in the presence of irradiated syngeneic peptide-coated splenocytes to culture SIINFEKL-specific CD8 ϩ T cells. As shown in Fig. 3B , T cells capable of lysing SIINFEKLcoated target cells were isolated from C57BL/6 (H-2 b ) mice infected with either 10 7 or 10 8 CFU of E. coli-OVA/LLO. This suggests that abundant amounts of OVA protein or partially digested peptides derived from OVA were released into the host cell cytosol and were processed and presented to naive CD8 ϩ T cells. OVA-specific CD8 ϩ T cells were not detected in the cultures derived from mice infected with E. coli-OVA, indicating that expression of LLO was required to release the Ag into the host cell cytosol.
To assess the amount of LLO being delivered into the cytosol by the E. coli-OVA/LLO strain, we also infected BALB/c (H- (Fig. 3C) . These results suggest that although LLO was expressed by E. coli-OVA-LLO in vivo and appeared to form enough pores in phagocytic membranes to release proteins that were abundantly expressed by the bacteria, large amounts of LLO protein were not likely to be released into the host cell cytosol during infection of mice.
The early IFN-␥ response occurs in C57BL/6 but not BALB/c mice
Many different strains of mice can be infected i.v. with L. monocytogenes, however, innate resistance to Listeria infection varies considerably between mouse strains. For example, the LD 50 for L. monocytogenes 10403s is 1 ϫ 10 4 in BALB/c mice and 50-fold higher (2 ϫ 10 5 ) in C57BL/6 mice. We postulated that rapid production of IFN-␥ by memory CD8 ϩ T cells would contribute significantly to innate resistance to Listeria infection and that susceptible BALB/c mice might lack this early IFN-␥ response. To test this, we infected groups of BALB/c and C57BL/6 mice with 5 LD 50 of L. monocytogenes and examined splenocytes 18 h postinfection to determine the total number of IFN-␥-secreting CD8 ϩ T cells. As shown in Fig. 4A , BALB/c mice given 5 ϫ 10 4 bacteria (5 LD 50 ) did not show an increase in the number of IFN-␥-secreting CD8
ϩ T cells compared with naive mice, while the comparable dose in C57BL/6 mice resulted in a significant increase in IFN-␥ ϩ CD8
ϩ T cells. Although the two strains of mice were each given an dose equal to 5 LD 50 , and thus, should have established equivalent infection in vivo, it was possible that a certain threshold of organisms was required to trigger the early IFN-␥ response. However, BALB/c mice that received 1 ϫ 10 6 L. monocytogenes still did not show a significant increase in IFN-␥ ϩ CD8 ϩ T cells 18 h postinfection. These data suggested that CD8 ϩ T cells were not involved in innate immune responses in BALB/c mice.
To further characterize the genetic difference between BALB/c and C57BL/6 mice involved in the early IFN-␥ response, we tested both C.B10 and BALB/c ϫ C57BL/6 F 1 mice. C.B10 is a BALB/c (H-2 d ) congenic strain that differs from BALB/c mice only at the MHC locus, which is derived from a C57BL/10 (H-2 b ) mouse. C.B10 mice infected with 1 ϫ 10 6 CFU of L. monocytogenes showed a slight but not significant increase in the number of IFN-␥ ϩ CD8 ϩ T cells 18 h postinfection (Fig. 4B ). This result suggested that the early IFN-␥ response is not linked to the MHC locus since C.B10 mice displayed the same phenotype as BALB/c mice. F 1 progeny derived from a BALB/c ϫ C57BL/6 cross showed an intermediate phenotype. Eighteen hours after infection, these mice had 3-fold more IFN-␥ ϩ CD8 ϩ T cells than BALB/c mice but fewer than C57BL/6 mice (Fig. 4C) . These data indicated that the genetic difference between BALB/c and C57BL/6 mice responsible for induction of the early IFN-␥ response displayed an incomplete dominance pattern.
The early IFN-␥ response correlates with innate host resistance against Listeria infection
We further examined whether or not the early IFN-␥ response by CD8
ϩ T cells correlated with innate resistance to L. monocytogenes infection by testing four additional strains of mice. As shown in Fig. 5A , the mouse strains could be classified into two groups-early IFN-␥ responders and nonresponders. C57BL/6, 129, and NZB mice each displayed a significant increase in the number of IFN-␥ ϩ CD8 ϩ T cells 18 h after infection with L. monocytogenes. As observed for the BALB/c mice, an early IFN-␥ response was not detected in either A/J or SJL mice (Fig. 5A) . To assess the level of innate resistance or susceptibility to Listeria infection, we infected each of these mouse strains with 2 ϫ 10 3 CFU of L. monocytogenes. Three days later, the total number of CFU present in the liver was determined. BALB/c and A/J mice (early IFN-␥ nonresponder strains) each had significantly higher bacterial burdens in the liver compared with C57BL/6 mice (Fig. 5B) . In addition, SJL mice had higher bacterial titers in the liver compared with either C57BL/6, 129, or NZB mice, although the difference was not statistically significant. Thus, the bacterial load early during the course of Listeria infection inversely correlated with the presence of innate CD8 ϩ T cells capable of secreting IFN-␥.
Listeria-infected macrophages isolated from either early IFN-␥ responder or nonresponder mice can trigger CD8 ϩ T cells to rapidly secrete IFN-␥
To begin to identify the cell type responsible for host differences in triggering the early IFN-␥ effect, we designed an in vitro assay to recapitulate the response observed in mice. BMM isolated from a C57BL/6 mouse were infected with L. monocytogenes, and 1 h later, splenocytes from a naive C57BL/6 mouse were added. After 14 -16 h of coincubation, GolgiPlug (brefeldin A) was added to block protein secretion, and the number of CD8 ϩ T cells expressing IFN-␥ was determined by intracellular cytokine staining 4 h later. As shown in Fig. 6A , ϳ5% of the CD8 ϩ T cells from naive C57BL/6 spleen were producing IFN-␥ 16 h after exposure to L. monocytogenes-infected BMM. All of the IFN-␥ ϩ CD8 ϩ cells expressed high levels of CD44, suggesting that they were memory T cells. Addition of anti-IL-12 and anti-IL-18 mAbs completely blocked the IFN-␥ response, indicating that it was TCR independent (Fig. 6A) . Thus, the IFN-␥-secreting cells detected in the in vitro assay had the same characteristics that have been described for the innate CD8 ϩ T cell response detected ex vivo. When the BMM were infected with an LLO deletion mutant strain of L. monocytogenes, only a few IFN-␥ ϩ CD8 ϩ T cells were detected (Fig. 6A) . Since LLO was not actively secreted by this strain, these data suggest that there may be an alternate pathway leading to low levels of IL-12/IL-18-dependent IFN-␥ secretion that does not require LLO-mediated cytosolic localization of the bacteria. However, as shown in vivo, LLO was required to induce the majority of the memory CD8 ϩ T cells to secrete IFN-␥. We next mixed cells from C57BL/6 and C.B10 mice to determine whether the infected macrophage or the responding CD8 ϩ T cell was responsible for the mouse strain differences we observed. We used C.B10 mice to avoid MHC mismatch during the assay, since C.B10 mice, like BALB/c mice, do not demonstrate the early IFN-␥ effect (Fig. 5B) . When naive C.B10 splenocytes were incubated with Listeria-infected C.B10 BMM in vitro, a 4-fold increase in the number of IFN-␥ ϩ CD8 ϩ T cells was detected (Fig. 6B) , compared with the 22-fold increase in IFN-␥ ϩ T cells detected for C57BL/6 mice (Fig. 6A) . These data indicate that as in vivo, C.B10 memory CD8 ϩ T cells do not display a robust early IFN-␥ response. C.B10 splenocytes showed the same low level IFN-␥ response when incubated with heterologous C57BL/6 BMM; however, C57BL/6 splenocytes rapidly produced IFN-␥ in response to C.B10-infected BMM (Fig. 6B) . Therefore, the responding splenocyte population, rather than the infected macrophage, seemed to be responsible for determining whether or not a robust early IFN-␥ response would occur.
Both DC and macrophages are required to induce CD44 high CD8 ϩ T cells to rapidly secrete IFN-␥
To verify that the responding CD8 ϩ T cells were the critical cell population that determined whether the early IFN-␥ response would be induced, we used CD8 ϩ -enriched splenocytes as a source of T cells in the in vitro assay rather than whole naive spleen. Surprisingly, CD8
ϩ T cells isolated from C57BL/6 mice did not secrete IFN-␥ following exposure to L. monocytogenesinfected autologous BMM (Fig. 7) . This suggested that an additional population of cells found in C57BL/6 spleen was required to trigger the early IFN-␥ response. Accordingly, we found that adding CD11c ϩ splenocytes to the in vitro assay resulted in a partial reconstitution of the early IFN-␥ response (Fig. 7) . Coincubation of either uninfected or Listeria-infected CD11c ϩ cells with naive CD8 ϩ T cells and Listeria-infected BMM resulted in the same percentage (ϳ1.0%) of IFN-␥ ϩ CD44 high CD8 ϩ T cells 18 h later, suggesting that the DC did not need to be directly infected with L. monocytogenes. As shown in Fig. 7 , coincubation of infected DC alone with CD8 ϩ T cells did not trigger the CD44 high CD8 ϩ T cells to secrete IFN-␥, indicating that both macrophages and DC were required to induce memory CD8 ϩ T cells to rapidly secrete IFN-␥. The maximum number of T cells rapidly secreting IFN-␥ (ϳ6% of CD8 ϩ T cells) was achieved only in the presence of whole naive spleen. Collectively, these results suggest that interactions between a Listeria-infected macrophage and a DC population are required to induce CD44 high CD8 ϩ T cells to rapidly secrete IFN-␥ and that interactions with other cell types in the spleen may enhance this response.
CD8 ϩ T cells that rapidly secrete IFN-␥ do not express higher levels of IL-12 receptor
A recent study suggested that the memory CD8 ϩ T cells capable of rapidly secreting IFN-␥ in C57BL/6 mice may have higher levels of IL-12 and IL-18 receptors on their surface (8). We did not observe a difference in IL-12R␤1 staining on the surface of naive C57BL/6 splenocytes compared with C.B10 splenocytes. For both strains of mice, ϳ2.0% of splenic CD8 ϩ T cells were IL-12R␤1 ϩ (data not shown). Eighteen hours after infection with L. monocytogenes, the number of IL-12R␤1 ϩ cells increased to ϳ4% of splenic CD8 ϩ cells in C57BL/6 mice while the number of IL-12R␤1 ϩ CD8 ϩ T cells in the spleens of BALB/c or C.B10 mice stayed the same (Fig. 8) . However, the majority of CD8 ϩ cells that expressed IFN-␥ ex vivo following L. monocytogenes infection did not express high levels of IL-12R␤1 (Fig. 8) . These results indicate that high levels of IL-12R on the cell surface are not required in order for CD44 high CD8 ϩ T cells to rapidly secrete IFN-␥ and suggest that there are other differences between C57BL/6 and BALB/c splenocytes that account for the differential ability to rapidly secrete IFN-␥ in response to Listeria infection.
Discussion
It has long been known that BALB/c mice are more susceptible to L. monocytogenes infection than C57BL/6 mice (21). We previously showed that 3 days postinfection with L. monocytogenes, C57BL/6 mice have well-defined granulomas in the liver, while the more susceptible BALB/c mice showed only neutrophil-rich microabscesses that were characteristic of an acute inflammatory response (1) . Granuloma formation is a CD4 ϩ T cell-dependent process that requires secretion of both TNF-␣ and IFN-␥ (22, 23) . In this report, we show that early expression of IFN-␥ by CD44 high CD8 ϩ T cells directly correlates with innate resistance to L. monocytogenes infection. Our data are consistent with the hypothesis that rapid production of IFN-␥ by memory CD8 ϩ T cells leads to accelerated granuloma formation and walling off of bacteria in the resistant C57BL/6 mice. In strains of mice that lack the early IFN-␥ response, acute inflammation continues, and the Listeria are able to spread from cell-to-cell, resulting in a larger bacterial burden. NK cells are also a significant source of IFN-␥, and we did find that a greater percentage of NK cells from C57BL/6 mice compared with BALB/c mice were also secreting IFN-␥ 18 h after infection with L. monocytogenes (our unpublished observation). However, Berg et al. (12) recently showed that IFN-␥-secreting memory CD8 ϩ T cells, and not NK cells, colocalized with foci of L. monocytogenes infection in both the spleen and the liver. These observations suggest that IFN-␥ secreted by memory CD8 ϩ T cells may be more effective in promoting granuloma formation at sites of infection.
The early IFN-␥ effect was not observed following infection with other pathogens, suggesting that a unique product made by L. monocytogenes may be responsible for triggering this event. We showed here that infection with L. monocytogenes strains that were not actively secreting LLO did not trigger the early IFN-␥ effect. Furthermore, infection with an E. coli strain expressing LLO did result in rapid IFN-␥ expression in C57BL/6 mice. LLO is a poreforming, cholesterol-dependent cytolysin that is essential for L. monocytogenes to escape from phagocytic vacuoles in most host cell types (24, 25) . It is not yet clear whether LLO itself triggers the response or whether LLO is needed simply to allow for cytosolic localization of another bacterial product. The fact that we observed a weaker response during infection with E. coli OVA/ LLO where the cytosolic LLO concentration was limiting (Fig.  3C ) strongly suggests that LLO is directly responsible for triggering the early IFN-␥ effect. However, it is also possible that a bacterial product, such as DNA, that is common to both E. coli and L. monocytogenes induces the response and that much more of this bacterial product is released into the cytosol during Listeria infection than during E. coli OVA/LLO infection.
A significant amount of work from Mitsuyama's laboratory (16, 17, 26, 27) has shown that coincubation of murine splenocytes with purified recombinant cholesterol-dependent cytolysins (CDC) such as LLO can trigger secretion of various cytokines, including IL-6 and IFN-␥. These in vitro data suggest that LLO alone can induce a population of cells in the spleen to secrete IFN-␥ within 24 h. Nomura et al. (17) further showed that neutralization of IL-12 and IL-18 resulted in an inhibition of IFN-␥ production by spleen cells exposed to purified LLO in vitro. Therefore, cytokine production induced by LLO was an IL-12-and IL-18-dependent process, as has been observed for the early IFN-␥ response by memory CD8 ϩ T cells. However, in these earlier in vitro studies, IFN-␥ expression was measured by RT-PCR or ELISA, and the splenocyte populations producing the IFN-␥ were not identified.
One mechanism by which LLO could result in IFN-␥ secretion would be to form pores in the cell membrane, allowing for calcium and/or potassium flux in the cell, triggering a signaling pathway that leads to cytokine production (28) . However, LLO has an acidic pH optimum and is thought to be significantly more cytolytic in phagocytic vacuoles than in the host cell cytosol or in tissue culture medium with a neutral pH (29, 30) . Alternatively, another domain of LLO, not involving the C-terminal active site, could be important for triggering a signaling cascade that results in IFN-␥ production. Investigators from Mitsuyama's laboratory (31, 32) showed that truncated versions of either recombinant LLO or the related toxin pneumolysin that lacked the C-terminal active site were still capable of inducing spleen cells to secrete IFN-␥ in vitro. In another study, Gekara et al. (33) pretreated LLO with cholesterol to block cytolytic activity and showed that this did not affect the ability of LLO to induce tyrosine phosphorylation in J774 cells, a process that appeared to be dependent on oligomerization of LLO and aggregation of lipid rafts. These data suggest that the cytokine-inducing activity of CDC proteins may be localized to the N terminus and argue against the hypothesis that LLO triggers IFN-␥ production simply by forming pores that allow for calcium flux. However, in these in vitro studies, cells were treated exogenously with purified recombinant forms of LLO in tissue culture medium, and it is not clear how much of the toxin may have been taken up by splenocytes or whether LLO acted only from outside the cell. Since exogenous treatment of cells with large quantities of LLO will likely result in cell damage that does not normally occur during intracellular infection, the mechanisms of LLO-induced cytokine production following in vitro treatment of cells may differ significantly from the effects of LLO in the host cell cytosol.
Recent work has demonstrated that cytosolic localization of L. monocytogenes activates multiple signaling pathways in macrophages (34 -37) . One downstream effect of these signaling events is the production of IFN-␤, a type I IFN that has long been associated with antiviral immunity and more recently has been shown to have immunomodulatory effects on NK cells and T cells. Mice that lack the ability to either produce or respond to IFN-␤ are significantly more resistant to L. monocytogenes infection (38, 39) , and it has been suggested that induction of IFN-␤ may be deleterious to the host as it actually promotes L. monocytogenes pathogenesis (40) . Although there is some evidence to indicate that type I IFN can enhance expression of IFN-␥ by naive CD8 ϩ T cells (41) , other data suggest that IFN-␤ production inhibits IFN-␥ expression during infection of mice (42) . However, most of this work has been done in the context of viral infections that do not elicit a robust IL-12 response. Thus, it remains to be determined whether early production of IFN-␤ following cytosolic localization of L. monocytogenes is involved in the early IFN-␥ response by memory CD8 ϩ T cells. It is possible that more than one pathway can lead to rapid IFN-␥ production by memory CD8 ϩ T cells during L. monocytogenes infection. Kambayashai et al. (9) previously showed that CD44 high CD8 ϩ T cells from C57BL/6 mice rapidly produced IFN-␥ following injection with either LPS or dsRNA alone and that the secretion of IFN-␥ required IL-12 and IL-18 release by macrophages. Those data suggest a role for TLR-mediated signaling in the rapid production of IFN-␥. However, we did not observe an early IFN-␥ effect by CD8 ϩ T cells following infection with either E. coli or S. typhimurium, presumably because injection with large doses of purified LPS can result in the triggering of signaling pathways that are not activated during infection with live LPScontaining bacteria. A recent study showed that incubation of BMM with a variety of recombinant CDC toxins (including LLO) resulted in TNF-␣ and IL-6 mRNA expression in a TLR4-dependent manner, and the authors suggested that CDC toxins may in fact act as TLR4 agonists (43) . However, it is not known whether the basal amount of LLO secreted by extracellular L. monocytogenes would be great enough to trigger TLR4 signaling on the surface of host cells during in vivo infection. As shown in Fig. 6A , we did see a slight increase in IFN-␥ production by CD44 high CD8 ϩ T cells when C57BL/6 BMM were infected in vitro with 10 8 CFU of a LLO mutant strain of L. monocytogenes. This response may represent the basal level of activation that occurs following interaction of bacterial products with surface-exposed TLR, while infection with LLO-expressing Listeria or E. coli results in a greater level of IFN-␥ production via a different signal transduction cascade that is triggered in the host cell cytosol.
Although L. monocytogenes was the only microorganism we tested that triggered the early IFN-␥ effect, another bacterial pathogen has been shown to cause rapid production of IFN-␥ by CD8 ϩ T cells. Lertmemongkolchai et al. (10) showed that incubation of spleen cells from C57BL/6 mice with the Gramnegative bacterium Burkholderia pseudomallei resulted in significant production of IFN-␥ by CD44 high CD8 ϩ T cells within 15 h of infection. B. pseudomallei encodes a cluster of genes that is similar to the Shigella ipa/mxi/spa loci, and it is thought that these genes are responsible for promoting phagosome escape and intracellular survival of Burkholderia in macrophages (44) . It is not yet clear whether this early IFN-␥ effect is triggered by a B. pseudomallei protein with functional similarities to LLO or whether cytosolic localization of Burkholderia simply allows for detection of another bacterial product that may be found in both bacterial species.
Results from our in vitro assays indicate that both macrophages and DC are essential to induce CD44 high CD8 ϩ T cells to rapidly secrete IFN-␥. Although innate production of IFN-␥ by memory CD8 ϩ T cells is known to be dependent on both IL-12 and IL-18, it is not yet clear which cell type is the primary source of these cytokines. Liu et al. (45) showed that splenic DC harvested from C57BL/6 mice 6 h postinfection with L. monocytogenes expressed more IL-12 mRNA than DC harvested from Listeria-infected BALB/c mice, suggesting that DC may in fact be the key splenocyte population that determines whether a mouse will be an early IFN-␥ responder or nonresponder. Further work will be needed to determine which cell type(s) must come in direct contact with LLO (and/or other bacterial products derived from Lm) to trigger the early IFN-␥ effect.
Our data clearly shows that memory CD8 ϩ T cells have innate immune functions in C57BL/6 mice that are lacking in the more susceptible BALB/c mice. These results may help to explain differences in both innate and adaptive immune responses that have been observed by a number of investigators using the BALB/c and C57BL/6 mouse models of Listeria infection. In the future, it will be interesting to determine whether memory CD8 ϩ T cells in humans are also capable of responding to Listeria infection by rapidly secreting IFN-␥ and whether the ability to mount an early IFN-␥ response correlates with increased susceptibility to systemic infection with L. monocytogenes.
